Home

Sign Up

Diseases and Conditions › Pediatric Neurology › Guillian Barre Syndrome

Guillian Barre Syndrome

Shawn Aylward
More..

print

Guillian Barre Syndrome - Abstract

Guillain-Barre syndrome is an acute immune-mediated process resulting in injury to the peripheral nerves. It has a slight male predominance and a bimodal age distribution. Symptoms typically develop 3-6 weeks after an infection, often viral upper respiratory infections. Patients will complain of weakness that begins in the feet and ascends over time. If left untreated, it can cause weakness of the respiratory muscles and thus respiratory failure. Early diagnosis and treatment is paramount in reducing morbidity and mortality.

Guillian Barre Syndrome - Introduction

Guillain-Barre syndrome (GBS) is an immune-mediated process also referred to as acute inflammatory demyelinating polyneuropathy (AIDP). French neurologists Guillain, Barré and Strohl have been given credit for its description in a pair of WWI soldiers who developed acute areflexic paralysis with spontaneous recovery in 1916. The neuropathy usually affects the motor, sensory, and autonomic nerves in the extremities though it may also involve the ocular motor nerves, respiratory, facial, and bulbar muscles.

There is a broad differential in those presenting with acute weakness that can include stroke, encephalitis, acute poliomyelitis, acute myelopathy, myasthenia gravis, toxins, metabolic derangements (hypokalaemia, hypophosphataemia), myopathy, and disorders of periodic paralysis. Careful history and exam is able to localize the issue to the peripheral nerves, thus excluding cerebral, brain stem, spinal cord, cauda equina, muscle or neuromuscular junction causes. The differential for peripheral neuropathy includes AIDP, botulism, tick paralysis, post-rabies vaccine neuropathy, heavy metal/drugs, porphyria, diphtheria, and critical illness neuropathy.

References

×

References

1. Sladky J, Ashwal S. Inflammatory Neuriopathies. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, editors. Swaiman's Pediatric Neurology Principles and Practice. 5 ed. China: Elsevier Saunders; 2012. p. 1532-48.
2. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barre syndrome. The Journal of infectious diseases. 1997;176 Suppl 2:S92-8. Epub 1997/12/13.
3. Kinnunen E, Farkkila M, Hovi T, Juntunen J, Weckstrom P. Incidence of Guillain-Barre syndrome during a nationwide oral poliovirus vaccine campaign. Neurology. 1989;39(8):1034-6. Epub 1989/08/01.
4. Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barre cases after an oral poliovaccine campaign. Lancet. 1989;2(8660):440-1. Epub 1989/08/19.
5. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. American journal of epidemiology. 1979;110(2):105-23. Epub 1979/08/01.
6. Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, et al. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PloS one. 2014;9(1):e82222. Epub 2014/01/10.
7. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51(4):1110-5. Epub 1998/10/22.
8. Nguyen DK, Agenarioti-Belanger S, Vanasse M. Pain and the Guillain-Barre syndrome in children under 6 years old. The Journal of pediatrics. 1999;134(6):773-6. Epub 1999/06/04.
9. Bos AP, van der Meche FG, Witsenburg M, van der Voort E. Experiences with Guillain-Barre syndrome in a pediatric intensive care unit. Intensive care medicine. 1987;13(5):328-31. Epub 1987/01/01.
10. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). The New England journal of medicine. 1956;255(2):57-65. Epub 1956/07/12.
11. Yuki N, Hartung HP. Guillain-Barre syndrome. The New England journal of medicine. 2012;366(24):2294-304. Epub 2012/06/15.
12. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Annals of neurology. 1990;27 Suppl:S21-4. Epub 1990/01/01.
13. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet. 2005;366(9497):1653-66. Epub 2005/11/08.
14. Burns TM. Guillain-Barre syndrome. Seminars in neurology. 2008;28(2):152-67. Epub 2008/03/21.
15. Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain-Barre syndrome. Annals of neurology. 1990;28(1):65-9. Epub 1990/07/01.
16. Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group. Neurology. 1985;35(8):1096-104. Epub 1985/08/01.
17. Zafeiriou DI, Kontopoulos EE, Katzos GS, Gombakis NP, Kanakoudi FG. Single dose immunoglobulin therapy for childhood Guillain-Barre syndrome. Brain & development. 1997;19(5):323-5. Epub 1997/07/01.
18. Shahar E, Shorer Z, Roifman CM, Levi Y, Brand N, Ravid S, et al. Immune globulins are effective in severe pediatric Guillain-Barre syndrome. Pediatric neurology. 1997;16(1):32-6. Epub 1997/01/01.
19. Yata J, Nihei K, Ohya T, Hirano Y, Momoi M, Maekawa K, et al. High-dose immunoglobulin therapy for Guillain-Barre syndrome in Japanese children. Pediatrics international : official journal of the Japan Pediatric Society. 2003;45(5):543-9. Epub 2003/10/03.
20. Korinthenberg R, Monting JS. Natural history and treatment effects in Guillain-Barre syndrome: a multicentre study. Archives of disease in childhood. 1996;74(4):281-7. Epub 1996/04/01.
21. Roodbol J, de Wit MC, Aarsen FK, Catsman-Berrevoets CE, Jacobs BC. Long-term outcome of Guillain-Barre syndrome in children. Journal of the peripheral nervous system : JPNS. 2014;19(2):121-6. Epub 2014/05/28.

Variants >>

Variants
Outcomes
Guillian Barre Syndrome - Patient Education
Guillian Barre Syndrome - Presentation
Guillian Barre Syndrome - Diagnosis
Guillian Barre Syndrome - Treatment

ask a doctor

Infection In Children

Infection In Children

Recommended for you

Orthodontics

Orthodontics

First Aid Kits

First Aid Kits

Liver Diseases Nutrition

Liver Diseases Nutrition

Serum Osmolality

Emergency Drug Formula

Apnea–Hypopnea Index

Therapeutic Drug Levels

Dr. Ira Shah | Management of MTB in AIDS

Dr. Ira Shah | Management of MTB in AIDS

Dr. Ira Shah | Diagnosis of MDRTB and XDRTB - How early can you Spot?

Dr. Ira Shah | Diagnosis of MDRTB and XDRTB - How early can you Spot?

Dr Ira Shah | Rubella - How it spreads, rash, congenital rubella syndrome & Isolation.

Dr Ira Shah | Rubella - How it spreads, rash, congenital rubella syndrome & Isolation.

Pediatric Oncall Journal

Original Article Efficacy of Micronutrient Fortified Supplementary Foods (Ready to Cook and Ready to Eat) and Take-Home Ration (THR) in children with Moderate Acute Malnutrition (MAM) using Community Based Approach

Join Us

youtube

instagram

Pediatric Oncall

Pediatric Oncall

Medical Calculators

Medical Calculators

Drug Center

Pediatric Oncall Journal

Pediatric Oncall Journal

Parenting

Vaccine Reminder

Vaccine Reminder

Home

About Us
Link To Us
Terms & Conditions
Privacy Policy

Online Ordering Policy
Sitemap
Feedback

Partner Sites

HIV in Childern
Medical ADRIS
Vaccine Reminder
Pediatric Oncall Journal

Infection in Children - Part 3

New Arrival

Infection in Children - Part 3

Other Pediatric Oncall Books

Pediatric Drug Index

Dengue, Malaria, Leptospirosis & Typhoid

Infection in Children - Part 2

Case Rounds In Pediatric Liver Disorders

Infection In Children

View More Books

DMCA

COPYSCAPE

Copyright © 2001 - 2020 Pediatric Oncall All Rights Reserved. All trademarks used are the properties of their respective owners.

Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.